Chronic kidney disease-mineral and bone disorder

Results 181 to 190 of about 16,068 (199)

Molecular pathophysiology of chronic kidney disease–mineral and bone disorder: Focus on the fibroblast growth factor 23–Klotho axis and bone turnover dynamics

Experimental Physiology
Abstract Chronic kidney disease–mineral and bone disorder (CKD‐MBD) is a major complication of chronic kidney disease (CKD), characterized by disruptions in mineral metabolism, abnormal bone turnover and vascular calcification, which collectively increase the risk of fractures and cardiovascular disease.
Henry Sutanto, Decsa Medika Hertanto
exaly +2 more sources

Some of the next articles are maybe not open access.

Related searches:

chronic kidney disease
renal osteodystrophy
vascular calcification

klotho
medicine
phosphate

pth
calcification
ckd-mbd

Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients

Current Medicinal Chemistry, 2022
Ana CRISTINA SIMÕES E Silva +2 more
exaly

Circulating p-Cresyl Sulfate, Non-Hepatic Alkaline Phosphatase and Risk of Bone Fracture Events in Chronic Kidney Disease-Mineral Bone Disease

Toxins, 2021
Jia-Feng Chang, Chih-Yu Hsieh, Jian-Chiun Liou +2 more
exaly

Mineral and bone disorders in children with chronic kidney disease

Nature Reviews Nephrology, 2011
Claus Peter Schmitt, O Mehls, Schmitt Claus Peter +2 more
exaly

<p>Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives</p>

International Journal of Nephrology and Renovascular Disease, 2019
Bala Waziri, Raquel Duarte, Saraladevi Naicker +2 more
exaly